Navigation Links
Researchers use computational models to study fear
Date:9/30/2009

COLUMBIA, Mo. The brain is a complex system made of billions of neurons and thousands of connections that relate to every human feeling, including one of the strongest emotions, fear. Most neurological fear studies have been rooted in fear-conditioning experiments. Now, University of Missouri researchers have started using computational models of the brain, making it easier to study the brain's connections. Guoshi Li, an electrical and computer engineering doctoral student, has discovered new evidence on how the brain reacts to fear, including important findings that could help victims of post-traumatic stress disorder (PTSD).

"Computational models make it much easier to study the brain because they can effectively integrate different types of information related to a problem into a computational framework and analyze possible neural mechanisms from a systems perspective. We simulate activity and test a variety of "what if" scenarios without having to use human subjects in a rapid and inexpensive way," Li said.

From previous experiments, scientists have found that fear can subside when overcome with fear extinction memory, but it is not permanently lost. Fear extinction is a process in which a conditioned response to a stimulant that produces fear gradually diminishes over time as subjects, such as rats in auditory fear experiments, learn to disassociate a response from a stimulus. One theory has concluded that fear extinction memory deletes fear memory, and another concluded that fear memory is not lost, but is inhibited by extinction memory as fear can recover with the passage of time after extinction.

"Fear extinction memory is not well understood, and our computational model can capture the neuron response well in rat during auditory fear conditioning with a mixture of mathematics and biophysical data," said Li. "Our main contribution is that our model predicts that fear memory is only partially erased by extinction, and inhib
'/>"/>

Contact: Kelsey Jackson
JacksonKN@missouri.edu
573-882-8353
University of Missouri-Columbia
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Researchers develop an integrated treatment for veterans with chronic pain and posttraumatic stress
2. UT Houston, Jamaica researchers launch autism study
3. Paul Marks prize recognizes 3 young cancer researchers
4. Van Andel Institute researchers find gene that could lead to new therapies for bone marrow disease
5. Mayo researchers find few side effects from radiation treatment given after prostate cancer surgery
6. U of T researchers create microchip that can detect type and severity of cancer
7. Researchers believe hormone therapy should not be stopped prior to mammograms
8. McMaster researchers discover a new antibacterial lead
9. BUSM researchers propose a relationship between androgen deficiency and cardiovascular disease
10. UCI researchers create new strategy for highly selective chemotherapy delivery
11. UCI researchers create new strategy for highly-selective chemotherapy delivery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 2014 As concerns about the ... morcellators ( http://www.gynecaremorcellatorlawsuit.com/ ) in gynecological surgeries mount, ... the continued use of uterine morcellation by some ... discouraged these procedures. According to The Wall Street ... risks associated with power morcellators are overblown, and ...
(Date:9/22/2014)... CareFlight Air & Mobile Services ... new AS365 N3+ Dauphin, the latest version of Airbus ... is based at Miami Valley Hospital in ... medical transport helicopters. , “We have a lot of ... Vice President, Emergency, Trauma, and CareFlight. “We’ve been operating ...
(Date:9/22/2014)... 2014 PCI (Project Concern International) ... equip women around the world with tools and training ... Women Empowered (WE) Initiative announced at the CGI Annual ... to pool their savings, invest in their own businesses, ... to ending poverty in the world, and through our ...
(Date:9/22/2014)... NY (PRWEB) September 22, 2014 The ... the Department of Surgery at the Icahn School of ... Doctors New York Group for Plastic Surgery gives residents ... access to a team of world-renowned plastic surgeons performing ... C. Andrew Salzberg, MD, who led NYGPS, was named ...
(Date:9/22/2014)... WHO: LiveOps, Inc., the global ... solutions. , WHAT: The 10th annual Customer Response ... for the connected consumer. Constant change in technology ... challenges and opportunities for customer experience executives. The ... practices, network and learn from fellow attendees, speakers ...
Breaking Medicine News(10 mins):Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 2Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 3Health News:Power Morcellator News: Bernstein Liebhard LLP Notes New Report Detailing Continued Use of Uterine Morcellation Despite FDA Warning 4Health News:Miami Valley Hospital CareFlight begins Service with AS365 N3+ 2Health News:Miami Valley Hospital CareFlight begins Service with AS365 N3+ 3Health News:PCI Announces New Effort to Empower 250,000 Women Worldwide at 2014 Clinton Global Initiative (CGI) Annual Meeting 2Health News:PCI Announces New Effort to Empower 250,000 Women Worldwide at 2014 Clinton Global Initiative (CGI) Annual Meeting 3Health News:The New York Group for Plastic Surgery Joins Mount Sinai Doctors 2Health News:The New York Group for Plastic Surgery Joins Mount Sinai Doctors 3Health News:LiveOps To Lead Panel Discussion At Customer Response Summit Memphis 2
... CLARA, Calif., January 8 Align Technology,Inc. (Nasdaq: ... that the,Company will report fourth quarter and fiscal year ... close of market. Financial results will,be released over PR ... the,Investor Relations section of the Company,s website at, http://investor.aligntech.com ...
... TEAC America, Inc. launches its,next generation P-55C dye-sublimation ... available, during the CES Show at,the Las Vegas Convention ... The P-55C printer can be integrated with 3 TEAC ... With TEAC,s,AL220S and AL550S, customers can print up to ...
... Vyvanse as the Clinical Gold Standard, According to ... 8 Decision Resources, one of the world,s ... and healthcare issues, finds that physicians indicate there ... effective nonstimulant therapy approved for adult attention-deficit/hyperactivity disorder ...
... (Nasdaq: GHDX ) today announced the appointment ... president and chief operating officer,Popovits is now the president ... Cole has been appointed as chief operating officer and ... reporting to Popovits. , "Kim,s ...
... and FirstDoc (Documentum) Solutions Deliver Regulatory Document Management ... CSC (NYSE: CSC ) announced today ... content management (ECM) solutions, adding features designed to ... the document life cycle and the growing collaboration ...
... will force hospitals to reconsider or defer purchases ... GroupWALTHAM, Mass., Jan. 8 According to Millennium ... RIS, and CVIS 2009 report, the budgetary ... affect the markets for picture archiving and communication ...
Cached Medicine News:Health News:Align Technology to Announce Fourth Quarter and Fiscal Year 2008 Results on January 28, 2009 2Health News:TEAC America Launches its Next Generation P-55C Printer, World's Fastest Dye-Sublimation Disc Printer 2Health News:Physicians Express Continued Need for Safe and Effective Nonstimulant Therapies in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder 2Health News:Physicians Express Continued Need for Safe and Effective Nonstimulant Therapies in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder 3Health News:Genomic Health Announces Management Changes and New Responsibilities 2Health News:Genomic Health Announces Management Changes and New Responsibilities 3Health News:Genomic Health Announces Management Changes and New Responsibilities 4Health News:CSC Announces New Releases of Enterprise Content Management Solutions for Life Sciences Industry 2Health News:CSC Announces New Releases of Enterprise Content Management Solutions for Life Sciences Industry 3Health News:Budgetary Constraints on Health Care Facilities to Affect PACS, RIS, and CVIS Markets 2
(Date:9/22/2014)... WASHINGTON , Sept. 22, 2014 ... deadline of Monday, Sept. 29 at 5 p.m. ... for Kids!" competition, in response to continued strong ... of $50,000 each will be awarded to the ... Pediatric Surgical Innovation Symposium hosted by Children,s National ...
(Date:9/22/2014)... 22, 2014  Elusys Therapeutics, Inc. (Elusys), a ... disease, today announced it has completed three phase ... (ETI-204). Obiltoxaximab is an anti-toxin in development for ... these studies support the safety and tolerability of ... intended therapeutic dose. The conclusion of these studies ...
(Date:9/22/2014)... , Sept. 22, 2014  Continua and ... in healthcare technology, media and telecommunications,  have formed ... China and promote international ... BHG announced this new partnership during the global ... Washington, DC , while also ...
Breaking Medicine Technology:Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 2Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 3Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 2Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 3Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 4Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 5Elusys Announces Results From Three Phase 3 Safety Studies Of Its Anthrax Anti-Toxin, Obiltoxaximab (ETI-204), In Adult Volunteers And Completion Of Its Phase 3 Clinical Development Program 6Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 2Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 4
... There are some two dozen oncology therapies in Phase ... development. While only some of these therapies will make it ... a competitive marketplace where success revolves around planning as much ... in the oncology therapeutic area must constantly evaluate which factors ...
... April 20, 2012 A recent clinical trial conducted at ... drug used to treat Parkinson,s Disease greatly improves the quality ... such as tremors, slowness, stiffness and difficulty walking. ... hold the trial, which was led by Dr. C. Warren ...
Cached Medicine Technology:Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector 2Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinson's Disease 2Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinson's Disease 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: